• Coronavirus: SkyCity share price falls as NZ restrictions tighten

    Casino Bad Hand Poker 16.9

    Casino Bad Hand Poker 16.9Casino Bad Hand Poker 16.9

    A number of Kiwi companies are providing an update this morning as New Zealand tightens its coronavirus restrictions. The SKYCITY Entertainment Group Limited (ASX: SKC) share price is down 5.16% at the time of writing  after the gaming group provided an update on the operational impacts.

    What did SkyCity announce?

    SkyCity advised that its Auckland casino and entertainment facilities would be closed.

    This comes as the New Zealand Government reinstates COVID-19 restrictions after four new cases popped up in Auckland. The government said late on Tuesday night that the new cases were likely to be from community transmission.

    SkyCity’s Auckland hotels will remain open to accommodate existing guests currently staying in-house, pending further advice.

    The SkyCity share price could be one to watch in early trade as investors react to the news.

    Notably, SkyCity’s Adelaide Casino is unaffected by the latest targeted restrictions and remains open.

    What does this mean for the SkyCity share price?

    Further lockdowns can’t be good news for the SkyCity share price. While New Zealand managed 102 days without any known COVID-19 cases, that streak has now come to an end.

    Shares in the Kiwi entertainment group are down 35.7% in 2020 largely thanks to the March bear market.

    The big question for investors is just how long the latest restrictions will last. If New Zealand can quickly contain the outbreak, the earnings impact of the Auckland casino shutdown may be minimal.

    What about other ASX entertainment shares?

    It’s worth keeping an eye on some of SkyCity’s ASX peers this morning.

    I think the Star Entertainment Group Ltd (ASX: SGR) share price could be one to watch.

    Star Entertainment shares have fallen 41.0% this year as investors fear a long period of reduced foot traffic. That’s partly due to coronavirus capacity restrictions and also immigration restrictions preventing VIP visits.

    Both the Star and SkyCity share prices are significantly underperforming the S&P/ASX 200 Index (ASX: XJO) which is down 8.2% in 2020.

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sky City Entertainment Group Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Coronavirus: SkyCity share price falls as NZ restrictions tighten appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3iwlTUd

  • Results: News Corp share price on watch as net profit drops 919%

    cup of coffee next to newspaper open to stock market page

    cup of coffee next to newspaper open to stock market pagecup of coffee next to newspaper open to stock market page

    Shares in Aussie media group News Corporation (ASX: NWS) are worth watching today after the company filed its latest regulatory filing. The News Corp share price could be on the move after the company announced a 919% fall in net income to a total US$1,269 million loss.

    What did News Corp report?

    The huge drop in profit is largely due to impairment charges against the company’s Foxtel and North America Marketing segments.

    It’s also worth noting that last week’s fourth-quarter earnings announcement provided a fair bit of detail to investors.

    The media group reported that loss on weaker FY20 revenues which fell 11% to US$9,008 million. News Corp did not announce a final dividend, leaving the total dividend for Class B Common Stock at US 20 cents per share from the interim payment.

    Net tangible asset backing per share totalled US$4.37 in FY20 which is down 6.6% from last year.

    News Corp’s operations are divided into six reporting segments comprising Digital Real Estate Services, Subscription Video Services, Dow Jones, Book Publishing, News Media and Other.

    News Media remains the company’s largest contributor by revenue, contributing 31.1% of total earnings. Subscription Video Services, including Kayo, comprised 20.9% while Book Publishing contributed a further 18.5%.

    The company’s Digital Real Estate Services line consists of News Corp’s 61.6% interest in REA Group Limited (ASX: REA). Segment revenue edged 8% lower while earnings before interest, tax, depreciation and amortisation (EBITDA) fell 9% to $345 million.

    I think the News Corp share price is one to watch this morning as investors take in the latest numbers.

    Free cash flow for the group fell 15.5% to US$180 million in FY20 with higher capital expenditure and lower operating cash flow weighing on the earnings figure.

    Net assets fell 9.2% to US$14,261 million in FY20 as goodwill and receivables fell from FY19 levels.

    COVID-19 impact

    The News Corp share price has been hit hard by the coronavirus pandemic with management providing an update on COVID-19 impacts. Management noted economic volatility, uncertainty and disruption as key factors affecting its various business lines.

    Some of the other COVID-19 risks highlighted by management included:

    • Lower revenue and profitability as advertising revenues continue to fall
    • Supply chain disruptions, particularly in printing and manufacturing
    • Company efforts to manage COVID-19 impacts may not be successful, resulting in additional costs
    • Adverse workforce impacts arising from the pandemic

    Foolish takeaway

    The News Corp share price is up 13.3% since the company’s fourth-quarter earnings release last Friday.

    I think it’s worth watching the Aussie media share to see how investors react to this morning’s update.

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has recommended REA Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Results: News Corp share price on watch as net profit drops 919% appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3fL9vOB

  • SEEK share price on watch after COVID-19 profit hit

    SEEK Share Price

    SEEK Share PriceSEEK Share Price

    The SEEK Limited (ASX: SEK) share price could be on the move on Wednesday after the release of the job listings company’s full year results.

    How did SEEK perform in FY 2020?

    It has been a difficult year for SEEK due to the coronavirus pandemic and its negative impact on listing volumes.

    For the 12 months ended 30 June 2020, SEEK delivered a 2.6% increase in revenue to $1,577.4 million. This growth was driven entirely by its SEEK Investments segment, which includes the China-based Zhaopin business. It posted a 15% increase in segment revenue to $947.8 million, which offset an 11% decline in AP&A revenue to $629.6 million. The AP&A segment includes the SEEK ANZ business, which recorded a 12% decline in revenue to $387.2 million in FY 2020.

    SEEK’s reported earnings before interest, tax, depreciation, and amortisation (EBITDA) came in at $414.9 million, down 9% from $455 million in FY 2019. On this occasion, a 20% increase in SEEK Investments EBITDA to $151.7 million, wasn’t enough to offset a 17% decline in AP&A EBITDA to $295 million.

    On the bottom line, SEEK’s reported net profit after tax (excluding significant items) was down 51% to $90.3 million. Those significant items relate to impairment charges of $198.4 million and funding related costs of $3.6 million. Including these significant items, SEEK recorded a net loss after tax of $111.7 million.

    In light of this loss and current economic conditions, no final dividend was declared. Once economic conditions improve, management intends to resume the payment of dividends.

    Outlook.

    SEEK’s CEO and Co-Founder, Andrew Bassat, is cautious on the near term, but remains very positive on SEEK’s long term prospects.

    He said: “The current macro outlook is highly uncertain. Our near-term profits will be impacted by COVID-19 but our focus is on executing and investing for the long-term. We are confident our investment and long-term focus is the right approach as SEEK’s revenue opportunity remains large and under-penetrated. If we invest and execute well, we can take advantage on improving conditions in the near-term but also a much larger longer-term revenue opportunity.”

    Due to uncertain market conditions, SEEK is not providing any guidance, but has given investors an idea of what FY 2021 might look like.

    This is based on a number of assumptions such as ANZ and Asia job ad volumes recovering during FY 2021 but remaining below FY 2020 peaks. It also assumes gradual improvements in online billings for the Zhaopin business in the first half, before growing in the second half.

    Based on this, SEEK has suggested FY 2021 could see revenue of ~$1,470 million, EBITDA of ~$330 million, and a reported net profit after tax of ~$20 million. This represents declines of 6.8%, 20.5%, and 77.85%, respectively, on FY 2020’s result.

    Mr Bassat commented: “SEEK’s short-term results will be negatively impacted by the challenges of COVID-19. Over the longterm, our strategy and overall revenue opportunity remain intact albeit COVID-19 will likely impact the timeframe to achieve our A$5b revenue aspirations. We are confident in our strategy and growth prospects, and as a result we will continue to invest across ANZ, Asia, Zhaopin, OES and ESVs.”

    “When labour markets return to more normal conditions, we expect to generate a high ROI given our market leadership and track record of generating strong returns from investing in product, technology and data. The near-term will continue to pose challenges, but we will remain agile to take advantage of new growth opportunities as they arise. If we invest and execute well, we expect SEEK to emerge a stronger and better business from this challenging period,” he concluded.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro owns shares of SEEK Limited. The Motley Fool Australia has recommended SEEK Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post SEEK share price on watch after COVID-19 profit hit appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3kCC6cw

  • Why a new CEO is good for the A2 Milk share price

    woman with milk moustache holding glass of milk and giving thumbs up

    woman with milk moustache holding glass of milk and giving thumbs upwoman with milk moustache holding glass of milk and giving thumbs up

    The A2 Milk Company Ltd (ASX: A2M) share price has been a top ASX share for a long time. In fact, the Kiwi dairy share is up 34.5% in 2020 and 2,556.3% in the last 5 years.

    However, I think the unveiling of a new CEO could be a good sign for further growth.

    Who is the new A2 Milk CEO?

    A2 Milk on Tuesday announced its new leader with Geoffrey Babidge having been serving in an interim capacity since December 2019.

    The new man for the job is Hanesbrands’ president of innerwear, David Bortolussi.

    Mr Bortolussi will join the Kiwi dairy company in early 2021 with a base salary of $1.75 million.

    The A2 Milk share price edged 1.20% lower on Tuesday following the news but I believe it could climb higher in the medium-term.

    Why is that good for the A2 Milk share price?

    I think this represents a step in the right direction for A2 Milk and its corporate governance controls.

    CEO announcements are a hot topic for A2 Milk after former CEO Jayne Hrdlicka lasted just 18 months in the top job. 

    Ms Hrdlicka was gifted rights to 600,000 A2 Milk shares upon signing in July 2018.

    Those rights were sold almost as quickly as they were granted to net the former CEO a tidy profit without much risk in the company’s performance.

    That’s why I think the latest appointment could be good news for the A2 Milk share price.

    That seems to be the sentiment shared by prominent investors interviewed for an article in the Australian Financial Review (AFR).

    Importantly, Mr Bortolussi will not be able to sell any shares until he owns the equivalent of one year’s salary.

    That to me says that the A2 Milk board has learned its lesson. I like that the board is looking to re-align executive remuneration with shareholder interests.

    Stronger corporate governance and a CEO with “skin in the game” can only be a good thing for the A2 Milk share price.

    There are some challenges ahead, particularly with frosty Australia-China relations, but I’m quietly confident for 2021.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why a new CEO is good for the A2 Milk share price appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3kv5EJ3

  • Can the Kogan share price keep going?

    Miniature basket of parcels sitting on laptop keyboard signifying online shopping at retailer such as Kogan

    Miniature basket of parcels sitting on laptop keyboard signifying online shopping at retailer such as KoganMiniature basket of parcels sitting on laptop keyboard signifying online shopping at retailer such as Kogan

    The Kogan.com Ltd (ASX: KGN) share price has surged more than 495% from its lows in mid-March.

    Despite the bullish momentum, many investors would be questioning how much further the Kogan share price can keep going. Here’s what has led to the boom in the Kogan share price and what the future looks like for the online retailer.

    Lockdown fuelling Kogan’s growth

    Earlier this week, Kogan provided the market with an update on the company’s performance during July 2020. As at 31 July 2020, Kogan has reported an active customer base of 2,309,000, with the online retailer adding an additional 126,00 customers in July.

    Kogan reported a 110% increase in gross sales for July on a year-on-year basis. The company also saw a 130% surge in year-on-year gross profit for the period, with EBITDA for July reported at $10 million.

    The continued growth in Kogan epitomises how consumer behaviour has changed during the coronavirus pandemic. With more Australians confined to their homes, online retailers have benefited from consumer spending that was originally meant for travel and other activities.

    Brokers neutral on Kogan

    Broker Credit Suisse recently released a note on the Kogan share price. The note highlighted Kogan’s strong trading in July, however analysts were cautious in their outlook. Analysts noted that elevated online transaction and substitutions of spending due to the COVID-19 pandemic has allowed Kogan to gain substantial market share.

    However, analysts also highlighted that the Kogan share price may have peaked in the short term. They cited that the company’s trading performance in FY21 and beyond remains uncertain in terms of the investment required to drive further growth. The research note also forecasts that in the near term, Kogan will produce lower EBITDA per month in comparison to July 2020.

    As a result, analysts retained a neutral rating on the Kogan share price and slapped a valuation of $19.49 on the company’s shares. Kogan’s shares closed yesterday’s trading session at $20.87.

    Has the Kogan share price peaked?

    In my opinion, I think that the Kogan share price may have peaked in the short term. Analysts from Credit Suisse have echoed this point by highlighting the increased costs needed to sustain growth in the near term.

    However, I am also of the belief that the coronavirus pandemic has accelerated the shift to online retail. For this reason, I think that companies like Kogan have a promising long-term future. In addition, Kogan has planned for future growth with the company acquiring furniture and homewares retailer Matt Blatt in May.  

    Kogan is set to announce its results for FY20 next Monday 17 August.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd. The Motley Fool Australia has recommended Kogan.com ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Can the Kogan share price keep going? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2DUQwnv

  • MoneyMe share price surges, but is it sustainable?

    hand about to burst bubble containing dollar sign, asx shares, over valued

    hand about to burst bubble containing dollar sign, asx shares, over valuedhand about to burst bubble containing dollar sign, asx shares, over valued

    Yesterday Moneyme Ltd (ASX: MME) announced it had reached a lending milestone of $500 million, and that it was launching a new payments processing service. Consequently, the Moneyme share price shot up and finished the day 20.47% higher. The crux of the announcement was not that the company was launching a payments processing service, but that it would offer a buy now, pay later (BNPL) function at the point of sale. A business move headed up by former Zip Co Ltd (ASX: Z1P) sales professionals.

    I believe this exposes two core truths about the Australian fintech sector in 2020. First, the BNPL sector, or pay by instalments, is no longer revolutionary in Australia. And second, all of this and more is due to the failure of the big four Australian banks.

    The failure of the big four

    The big four banks are fundamentally mortgage providers, with business loans and digital payments thrown in. They have been woeful at defending their turf. For instance, by population Australia is a small country, dominated by four large banks protected by legislation. So how on earth did Tyro Payments Ltd (ASX: TYR) become the fifth largest merchant acquiring bank, after the big four, by number of terminals? Moreover, bank lending to households via credit cards has been falling significantly since 2002. The Australian aversion to consumer debt has been growing for almost two decades. So why didn’t any of them come up with Afterpay Ltd (ASX: APT)

    The Moneyme share price isn’t the only one to benefit by being more accessible, user friendly and offering cheap pricing. To paraphrase Paul Keating, every pet shop galah has an opinion on fintech shares these days. Companies like CML Group Ltd (ASX: CGR) provide cashflow solutions to small and medium sized companies through innovative debtor finance platforms. Additionally, lenders such as WISR Ltd (ASX: WZR) provide short term personal finance, while RAIZ Invest Ltd (ASX: RZI) is helping the public to save money.

    It is almost like watching the death of Borders Bookstores again after the rise of Amazon.com (NASDAQ: AMZN). Consequently, given that the big four banks have allowed these spaces to open up, what does this mean for Moneyme?

    Is the Moneyme share price sustainable?

    In my view, there is not a chance that the company’s share price is sustainable. Not in the medium term anyway. It announced it had acquired 55 merchants. Zip Co has 23,600. Moreover, its most similar payments competitor, Tyro, has 32,000 Australian merchants. Not only that, but a BNPL service is something Tyro could quickly open up at the point of sale.

    Furthermore, the Commonwealth Bank of Australia (ASX: CBA) is already doing so slowly via its part ownership of Klarna, the world’s largest BNPL company. To illustrate further just how competitive this sector is now, the Splitit Ltd (ASX: SPT) model of working with the large credit cards, to break down payments into instalments, is also likely to eat into market share. 

    Foolish takeaway

    The Australian buy now, pay later sector has become crowded to the point of normalcy. Accordingly, I believe the spike in the Moneyme share price is irrational optimism, not a sustainable valuation. Additionally, this is without considering the impacts of inevitable Australian regulation, and a raft of unlisted companies.

    I think there are plenty of other growth opportunities in the fintech sector generally. However, within the BNPL sector, I believe it is now a race for the United States market. The startup companies that can establish a beachhead in that $5 trillion retail market are the ones that will survive this modern day gold rush.

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Daryl Mather has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Amazon. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Tyro Payments and ZIPCOLTD FPO and recommends the following options: short January 2022 $1940 calls on Amazon and long January 2022 $1920 calls on Amazon. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended Amazon. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post MoneyMe share price surges, but is it sustainable? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3ixxEK4

  • CBA delivers $7.3bn cash profit and declares 98 cents per share final dividend

    Commonwealth bank

    Commonwealth bankCommonwealth bank

    The Commonwealth Bank of Australia (ASX: CBA) share price will be in focus this morning following the release of its full year results.

    How did Commonwealth Bank perform in FY 2020?

    For the 12 months ended 30 June 2020, Commonwealth Bank reported operating income of $23,758 million, up 0.8% on the prior corresponding period. This reflects volume growth in home lending and deposits, which offset a 2 basis point decline in its net interest margin to 2.07%.

    Management advised that home lending grew at 1.3x system growth due to strong operational execution. Household deposit balances grew 9.8% year-on-year, and spot transaction account balances were up 25%.

    The bank’s statutory net profit after tax including discontinued operations was $9,634 million, up 12.4% on FY 2019. This statutory result includes significant gains on the sale of businesses.

    Whereas the company’s cash net profit after tax from continuing operations was down 11.3% to $7,296 million. This was driven largely by higher COVID-19 loan impairment expense.

    Commonwealth Bank dividend.

    As was expected, Commonwealth Bank has cut its final dividend down materially following recent guidance by APRA.

    It has declared a 98 cents per share fully franked final dividend, which represents a dividend payout ratio of 49.95% of second half statutory earnings. This was in line with APRA’s guidance that banks should retain at least 50% of earnings

    This final dividend brings Commonwealth Bank’s full year dividend to $2.98 per share, which is down 31% on FY 2019’s dividend.

    At the end of the period, Commonwealth Bank’s CET1 ratio stood at 11.6%. This is up 90 basis points year on year and comfortably ahead of APRA’s ‘unquestionably strong’ benchmark of 10.5%.

    COVID-19 loan deferrals.

    Commonwealth Bank also provided the market with an update on its COVID-19 loan deferrals.

    As of the end of July, COVID-19 related home loan deferrals stood at 135,000 home loans. This represents 8% of total accounts and is down from a peak of 154,000 home loans.

    Approximately 59,000 business loans are currently being deferred. This represents 15% of its total balance and is down from 86,000 business loans at the peak.

    Management commentary.

    Commonwealth Bank’s Chief Executive Officer, Matt Comyn, was pleased with the company’s performance in a challenging environment.

    He said: “Despite the challenging environment, operational performance in the business remains strong. Combined with our strong balance sheet and capital position, this enables us to continue supporting customers and the economy. Using our strengths in customer service, technology and data we will check-in regularly with customers to assess their financial needs and to support their recovery.”

    “The next few months will be critical and some sectors will take longer to recover than others, however, we remain positive about Australia’s long-term prospects. We will also continue to work with government, regulators and our industry peers to support initiatives that stimulate economic activity and jobs,” he concluded.

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post CBA delivers $7.3bn cash profit and declares 98 cents per share final dividend appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3fPaGw8

  • Is the CSL share price the best ASX biotech buy right now?

    Digitised bubbles of cells representing ASX biotech shares such as CSL

    Digitised bubbles of cells representing ASX biotech shares such as CSLDigitised bubbles of cells representing ASX biotech shares such as CSL

    ASX biotech shares have been persistent outperformers in recent times. CSL Limited (ASX: CSL) is one of the largest ASX shares by market capitalisation with a $127.6 billion valuation based on the current CSL share price.

    However, CSL shares aren’t your only option for biotech exposure in the Aussie share market.

    What other ASX biotech shares are available?

    Polynovo Ltd (ASX: PNV) has been another top performer in recent years.  Polynovo’s proprietary NovoSorb BTM product has proven to be a highly successful solution in the treatment of severe burns.

    The Polynovo share price is now up 15.6% in 2020 and 1,854.6% in the last 5 years. That’s good news for investors who backed the ASX biotech share from an early stage.

    Then there’s Mesoblast limited (ASX: MSB). Mesoblast is an Aussie regenerative medicine company that provides treatments for inflammatory ailments, cardiovascular disease and back pain.

    The Mesoblast share price was hammered in yesterday’s trade after a United States Food and Drug Administration (FDA) report.

    The ASX biotech share crashed 31.0% lower after the release of the FDA briefing document. The FDA noted concerns about the clinical performance of Mesoblast’s treatment for paediatric steroid-resistant acute graft versus host disease.

    That’s disappointing news for shareholders but I think the long-term outlook for Mesoblast is still intact. The company still has some exciting products in Phase 3 trials which could be big money earners in the future.

    Is today’s CSL share price the best biotech buy?

    CSL is the obvious choice if you’re looking for safety. It has an extensive history of research and development (R&D) success and is a big fish in the industry.

    That blue-chip status could help the ASX biotech share in the current volatile market. It could also provide some piece of mind for investors who don’t want to buy a speculative growth share.

    However, I think there is also some potential upside for both Polynovo and Mesoblast. 

    Polynovo is looking to extend the application of the NovoSorb BTM product into other, lucrative industries. That includes breast augmentation and hernia treatment markets.

    For Mesoblast, I think a 31.0% share price drop could present a tasty buying opportunity. That’s a big mental hurdle to overcome for investors and you’d have to really believe in the company’s long-term success.

    However, ASX biotech shares can rise and fall with critical decisions on their products. That means I wouldn’t be writing off the Mesoblast share price solely based on the FDA announcement.

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Is the CSL share price the best ASX biotech buy right now? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3kAVSoJ

  • Up 30% in a week, is the Webjet share price a strong buy?

    plane flying across share markey graph, asx 200 travel shares, qantas share price

    plane flying across share markey graph, asx 200 travel shares, qantas share priceplane flying across share markey graph, asx 200 travel shares, qantas share price

    The Webjet Limited (ASX: WEB) share price jumped 5.6% yesterday and is now up 30% since last Monday. The Webjet share price has still been smashed in 2020 but is now seeing a strong recovery.

    The big question for value investors is whether or not now is a good time to buy.

    Why the Webjet share price is surging

    This is a perplexing question. The Webjet share price is rocketing higher despite tight coronavirus restrictions across the country.

    Prime Minister Scott Morrison was even quoted as saying internal borders may stay shut until Christmas.

    That’s not good news for the travel industry but hasn’t stopped investors piling in to Webjet shares recently.

    I believe some investors are thinking that part of the short-term danger has subsided.

    It could be that large institutional backers are buying back in and betting that Webjet’s insolvency risk is subdued.

    Whatever the reason, the Webjet share price has a lot of momentum behind it right now. So, is it a good time to buy?

    Are other ASX travel shares in the buy zone?

    I think Corporate Travel Management Ltd (ASX: CTD) has more to offer than the Webjet share price right now.

    The Aussie travel share jumped 4.4% higher yesterday and is now up 121.5% since 19 March.

    One reason I prefer Corporate Travel to Webjet is its significant earnings from the business and government sector.

    This has proven to be more resilient compared to leisure bookings. But it’s not just Corporate Travel that I’d prefer to buy over Webjet right now.

    Sydney Airport Holdings Pty Ltd (ASX: SYD) is another top travel share. 

    Sydney Airport straddles the line between travel and infrastructure given its significant underlying assets.

    Shares in the Aussie airport are down 37.5% this year as the company taps investors for a $2 billion capital raising.

    The group’s half-year earnings report contained some soft numbers but that was largely to be expected in the current climate.

    Foolish takeaway

    I won’t be buying into ASX travel shares just yet. I certainly don’t like to invest in things I don’t understand and the Webjet share price is one of those things.

    I will, however, be keeping an eye out for the Aussie travel agency’s full-year earnings report in August.

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Corporate Travel Management Limited and Webjet Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Up 30% in a week, is the Webjet share price a strong buy? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3aelQJZ

  • If you have $12,000, you should invest in these 3 ASX shares now

    Where to invest, portfolio, invest

    Where to invest, portfolio, investWhere to invest, portfolio, invest

    If you have $12,000 to invest into ASX shares then you’re in luck. There are plenty of quality options to choose from.

    The share market has rebounded strongly from the COVID-19 share market selloff a few months ago. There are plenty of ASX share ideas where prices may have reached almost as high as they can reach in the medium-term such as Coles Group Limited (ASX: COL) and Afterpay Ltd (ASX: APT).

    I want to invest in ASX shares where there’s likely to be strong profit growth over the long-term but the valuation still seems reasonable.

    If I had $12,000 to invest, this is where I’d put the money into these ASX shares:

    Share 1: Pushpay Holdings Ltd (ASX: PPH) $4,000

    Pushpay is one of the most exciting ASX growth shares in my opinion. It helps large and medium US churches to receive electronic donations. This is very useful during this COVID-19 era considering all of the social distancing and restrictions that is going on in the country. Pushpay also offers a livestreaming service to its church clients so it can still connect with its congregation.

    I think Pushpay has a lot of growth potential. It was generating growth before COVID-19 came along but the unfortunate circumstances have really brought forward the adoption curve.

    In FY20 it grew its revenue by a third to US$129.8 million and in FY21 it’s expecting to at least double its earnings before interest, tax, depreciation, amortisation and foreign currency (EBITDAF) to US$50 million..

    I’m impressed that its gross margin is growing at a strong rate – in FY20 its gross margin improved from 60% to 65%. I also thought its recent acquisition of Church Community Builder was a really smart move. The combined business has a stronger offering. The two businesses can also sell to each other’s customer base.

    Over the long-term the ASX share is aiming for US$1 billion of annual revenue which would make Pushpay a much bigger business if it achieves the goal.

    At the current Pushpay share price it’s trading at 30x FY23’s estimated earnings.

    Share 2: Bubs Australia Ltd (ASX: BUB) – $3,500

    I think Bubs is a quality business with a lot of growth potential. Its management have proven they can grow the infant formula business effectively. I like how it used acquisitions to secure its supply chain with its own Chinese-approved manufacturing facility.

    The ASX share has grown strongly over FY20 despite the issues relating to COVID-19.  FY20 revenue increased by 32% to $62 million. Its FY20 fourth quarter showed the international growth potential – Chinese direct sales increased 26% and other export market sales grew by 71%.

    I’m not expecting Bubs to be as globally successful as one of its competitors, but I think it has a very long growth runway geographically. It can expand with new products like Vita Bubs and the organic grass-fed cow milk infant formula range.

    Over the long-term I think this ASX share could grow substantially in size. The growing gross profit margin will help drive the bottom line higher.

    Share 3: WAM Microcap Limited (ASX: WMI) – $4,500

    WAM Microcap is a listed investment company (LIC) which targets ASX small caps with market caps under $300 million. It’s this hunting ground which can generate really strong long-term returns because not many investors are searching in this area.

    The investment team at Wilson Asset Management (WAM) have proven to be very effective at delivering strong returns.

    At 30 June 2020 its portfolio had made a gross return of 32.9% over the past three months and 15.9% per annum since inception in June 2017. I think the WAM team can continue to outperform over the long-term with the investment style and focus on ASX growth shares.

    Another of the attractive things about the LIC is the good dividend payments. WAM Microcap is growing its ordinary dividend and it keeps paying special dividends.

    At the current WAM Microcap share price it offers a grossed-up dividend yield of 5.75%.

    Foolish takeaway

    I think each of these ASX shares are capable of producing strong returns over the next five years. WAM Microcap offers great diversification, but I believe both Pushpay and Bubs can grow into much larger businesses over time.

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Tristan Harrison owns shares of WAM MICRO FPO. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of PUSHPAY FPO NZX. The Motley Fool Australia owns shares of and has recommended BUBS AUST FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO and COLESGROUP DEF SET. The Motley Fool Australia has recommended PUSHPAY FPO NZX. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post If you have $12,000, you should invest in these 3 ASX shares now appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3iAHL0X